Merkel Cell Carcinoma: A Comparison of Different Immunohistochemical Markers Useful in Diagnosis

Merkel cell carcinoma (MCC) is a rare and aggressive neuroendocrine carcinoma associated with a high mortality rate.  A polyomavirus integrated into the genome of most tumors is thought to be pathogenic.  MCCs may be difficult to distinguish from other small cell carcinomas, melanoma, lymphoma, and others.  Immunohistochemical marker studies are essential for accurate and efficient diagnosis. Although the paranuclear dot-like pattern seen with staining for cytokeratin 20 is considered characteristic, antibodies directed at other cytokeratins such as cytokeratin 8 (CAM 5.2), pancytokeratins (AE1/AE3), and other clones that recognize low molecular weight cytokeratins are also useful for diagnosis. We set out to evaluate which stains are helpful in diagnosing the cases of MCC encountered in our patient population.  A retrospective study of 59 cases of MCC from our files was performed. Each MCC was stained with a panel of IHC markers and evaluated for the staining pattern and intensity in an effort to identify the most efficient IHC stains useful in establishing a diagnosis of MCC. [N A J Med Sci. 2018;11(1):34-38.   DOI: 10.7156/najms.2018.1101034]

[1]  S. Tomlins,et al.  Next generation sequencing of Cytokeratin 20-negative Merkel cell carcinoma reveals ultraviolet-signature mutations and recurrent TP53 and RB1 inactivation , 2016, Modern Pathology.

[2]  G. Procop,et al.  Cytokeratin 20-negative Merkel cell carcinoma is infrequently associated with the Merkel cell polyomavirus , 2015, Modern Pathology.

[3]  P. Nghiem,et al.  How does the Merkel polyomavirus lead to a lethal cancer? Many answers, many questions, and a new mouse model , 2015, The Journal of investigative dermatology.

[4]  Wenqin Luo,et al.  Dual Innervation of Neonatal Merkel Cells in Mouse Touch Domes , 2014, PloS one.

[5]  H. Okabe,et al.  Merkel cell carcinoma concurrent with Bowen's disease: two cases, one with an unusual immunophenotype , 2013, Journal of cutaneous pathology.

[6]  Olga K Afanasiev,et al.  Merkel Polyomavirus-Specific T Cells Fluctuate with Merkel Cell Carcinoma Burden and Express Therapeutically Targetable PD-1 and Tim-3 Exhaustion Markers , 2013, Clinical Cancer Research.

[7]  Luciane T. Kagohara,et al.  PD-L1 Expression in the Merkel Cell Carcinoma Microenvironment: Association with Inflammation, Merkel Cell Polyomavirus, and Overall Survival , 2013, Cancer Immunology Research.

[8]  Arthur T. Johnson,et al.  Quantitative comparison of immunohistochemical staining measured by digital image analysis versus pathologist visual scoring , 2012, Diagnostic Pathology.

[9]  A. Chou,et al.  Immunohistochemistry for Merkel cell polyomavirus is highly specific but not sensitive for the diagnosis of Merkel cell carcinoma in the Australian population. , 2011, Human pathology.

[10]  Y. Narisawa,et al.  Merkel cell carcinoma with cytokeratin 20-negative and thyroid transcription factor-1-positive immunostaining admixed with squamous cell carcinoma. , 2011, Journal of dermatological science.

[11]  J. Ring,et al.  Immunohistochemical features of Merkel cell carcinoma in correlation with presence of Merkel cell polyomavirus DNA. , 2011, Acta dermato-venereologica.

[12]  K. Busam,et al.  Merkel Cell Polyomavirus Expression in Merkel Cell Carcinomas and Its Absence in Combined Tumors and Pulmonary Neuroendocrine Carcinomas , 2009, The American journal of surgical pathology.

[13]  M. Tsao,et al.  Overview of molecular testing in non-small-cell lung cancer: mutational analysis, gene copy number, protein expression and other biomarkers of EGFR for the prediction of response to tyrosine kinase inhibitors , 2009, Oncogene.

[14]  K. Busam,et al.  Merkel Cell Carcinoma: Review , 2009, Advances in anatomic pathology.

[15]  P. Moore,et al.  Clonal Integration of a Polyomavirus in Human Merkel Cell Carcinoma , 2008, Science.

[16]  S. Suster,et al.  Immunostaining for thyroid transcription factor 1 and cytokeratin 20 aids the distinction of small cell carcinoma from Merkel cell carcinoma, but not pulmonary from extrapulmonary small cell carcinomas. , 2001, Archives of pathology & laboratory medicine.

[17]  K. Jensen,et al.  Cytokeratin Staining in Merkel Cell Carcinoma: An Immunohistochemical Study of Cytokeratins 5/6, 7, 17, and 20 , 2000, Applied immunohistochemistry & molecular morphology : AIMM.

[18]  M. Scott,et al.  Cytokeratin 20: a marker for diagnosing Merkel cell carcinoma. , 1999, The American Journal of dermatopathology.

[19]  S. Suster,et al.  Cytokeratin 20 immunoreactivity distinguishes Merkel cell (primary cutaneous neuroendocrine) carcinomas and salivary gland small cell carcinomas from small cell carcinomas of various sites. , 1997, The American journal of surgical pathology.

[20]  R. Moll,et al.  Cytokeratin 20 in human carcinomas. A new histodiagnostic marker detected by monoclonal antibodies. , 1992, The American journal of pathology.